(Q45936598)

18 December 2017

title

Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy. (English)

1 reference

18 December 2017

author name string

Pamela A Moise

1

1 reference

18 December 2017

Ellie Hershberger

2

1 reference

18 December 2017

Maria I Amodio-Groton

3

1 reference

18 December 2017

Kenneth C Lamp

4

1 reference

18 December 2017

language of work or name

English

0 references

publication date

7 July 2009

1 reference

18 December 2017

Annals of Pharmacotherapy

published in

1 reference

18 December 2017

volume

43

1 reference

18 December 2017

issue

7

1 reference

18 December 2017

page(s)

1211-1219

1 reference

18 December 2017

Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000)

cites work

1 reference

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

21 January 2018

1 reference

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

21 January 2018

1 reference

Vancomycin: understanding its past and preserving its future

21 January 2018

1 reference

Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains

21 January 2018

1 reference

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study

21 January 2018

1 reference

Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis

21 January 2018

1 reference

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy

21 January 2018

1 reference

Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein

21 January 2018

1 reference

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin

21 January 2018

1 reference

Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections

21 January 2018

1 reference

Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens

21 January 2018

1 reference

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains

21 January 2018

1 reference

Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006).

21 January 2018

1 reference

Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.

21 January 2018

1 reference

Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis

21 January 2018

1 reference

Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin

21 January 2018

1 reference

Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin

21 January 2018

1 reference

In vivo pharmacodynamic activity of daptomycin

21 January 2018

1 reference

Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations

21 January 2018

1 reference

Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies.

21 January 2018

1 reference

Relationship between susceptibility to daptomycin in vitro and activity in vivo in a rabbit model of aortic valve endocarditis

21 January 2018

1 reference

Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects

21 January 2018

1 reference

Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers

21 January 2018

1 reference

A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria

21 January 2018

1 reference

Pacemaker-induced Staphylococcus aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from a coronary stent: Cure with prolonged/high-dose daptomycin without toxicity

21 January 2018

1 reference

Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program

21 January 2018

1 reference

Cubicin Outcomes Registry and Experience (CORE) methodology

21 January 2018

1 reference

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

21 January 2018

1 reference

Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis.

21 January 2018

1 reference

Daptomycin: a novel agent for Gram-positive infections.

21 January 2018

1 reference

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1M085

1 reference

18 December 2017

1 reference

18 December 2017